Centro de Infusion Marbella; Consultorios Royal Center Num 214
Panama City, Panama
About Centro de Infusion Marbella; Consultorios Royal Center Num 214
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Genentech, Inc.
1
Hoffmann-La Roche
1
Clinical Trials at Centro de Infusion Marbella; Consultorios Royal Center Num 214
During the past decade, Centro de Infusion Marbella; Consultorios Royal Center Num 214 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis
2009-10-31
2014-01-28
Completed
1,162
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Infusion Marbella; Consultorios Royal Center Num 214"
#1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centro de Infusion Marbella; Consultorios Royal Center Num 214
According to Clinical.Site data, the most researched conditions in "Centro de Infusion Marbella; Consultorios Royal Center Num 214" are
"Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Centro de Infusion Marbella; Consultorios Royal Center Num 214" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Infusion Marbella; Consultorios Royal Center Num 214
Most popular intervention types in "Centro de Infusion Marbella; Consultorios Royal Center Num 214" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Methotrexate" (2 trials), "Leflunomide" (1 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials) and "Placebo to methotrexate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Infusion Marbella; Consultorios Royal Center Num 214
The vast majority of trials in "Centro de Infusion Marbella; Consultorios Royal Center Num 214" are
2 trials for "All" genders.
Clinical Trials Status at Centro de Infusion Marbella; Consultorios Royal Center Num 214
Currently, there are NaN active trials in "Centro de Infusion Marbella; Consultorios Royal Center Num 214".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Centro de Infusion Marbella; Consultorios Royal Center Num 214,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Infusion Marbella; Consultorios Royal Center Num 214, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".